Borchmann, P., Haverkamp, H., Diehl, V., Cerny, T., Markova, J., Ho, A. D., . . . Engert, A. (2011). Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage Hodgkin's lymphoma: Final analysis of the HD12 trial of the German Hodgkin Study Group. Journal of clinical oncology, 29(32), . https://doi.org/10.1200/JCO.2010.33.9549
Chicago-Zitierstil (17. Ausg.)Borchmann, Peter, et al. "Eight Cycles of Escalated-dose BEACOPP Compared with Four Cycles of Escalated-dose BEACOPP Followed by Four Cycles of Baseline-dose BEACOPP with or Without Radiotherapy in Patients with Advanced-stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group." Journal of Clinical Oncology 29, no. 32 (2011). https://doi.org/10.1200/JCO.2010.33.9549.
MLA-Zitierstil (9. Ausg.)Borchmann, Peter, et al. "Eight Cycles of Escalated-dose BEACOPP Compared with Four Cycles of Escalated-dose BEACOPP Followed by Four Cycles of Baseline-dose BEACOPP with or Without Radiotherapy in Patients with Advanced-stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group." Journal of Clinical Oncology, vol. 29, no. 32, 2011, https://doi.org/10.1200/JCO.2010.33.9549.